Kansas Mental
Health Coalition

Bill in Conference Committee to Create Medicaid Mental Health Medications Advisory Committee

May 01, 2015 11:22 AM | Anonymous

Bill in Conference Committee to Create Medicaid Mental Health Medications Advisory Committee

Senate Sub for HB 2149 is currently in conference and expected to pass.  HB 2149 was originally a bill to provide for Medicaid coverage of donor breast milk.  The Senate added the provisions of SB 181 and a new plan for instituting management of mental health medications in Medicaid through a specialized advisory committee.  The bill amends the procedures regarding restrictions of patients’ access to any new prescription-only drug under the Kansas Medicaid Program and would establish meeting requirements for the Medicaid Drug Utilization Review Board (Board). 

Further, the bill would allow prior authorization or other restrictions on medications used to treat mental illness to be imposed on Medicaid recipients for medications subject to guidelines developed by the Board in accordance with provisions of the bill; establish instances not to be construed as restrictions; provide for the development of guidelines; establish requirements for Board review of medications used to treat mental illness available for use before and after July 1, 2015; and create a Mental Health Medication Advisory Committee (Committee), outlining Committee membership and appointments, meeting frequency, and member compensation.   

Advocates view the new provisions as a better option than SB 123 - which would have simply deleted the statutory exemption from Medicaid management for MH drugs.  SB 123 was defeated by the Senate.   Read more about this issue.



(c) Kansas Mental Health Coalition, P.O. Box 4744, Topeka, KS  66604  785-969-1617

Powered by Wild Apricot Membership Software